1. Home
  2. ITCI vs GGB Comparison

ITCI vs GGB Comparison

Compare ITCI & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • GGB
  • Stock Information
  • Founded
  • ITCI 2002
  • GGB 1901
  • Country
  • ITCI United States
  • GGB Brazil
  • Employees
  • ITCI N/A
  • GGB N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • GGB Steel/Iron Ore
  • Sector
  • ITCI Health Care
  • GGB Industrials
  • Exchange
  • ITCI Nasdaq
  • GGB Nasdaq
  • Market Cap
  • ITCI 8.0B
  • GGB 7.0B
  • IPO Year
  • ITCI N/A
  • GGB 1999
  • Fundamental
  • Price
  • ITCI $85.60
  • GGB $3.39
  • Analyst Decision
  • ITCI Strong Buy
  • GGB Strong Buy
  • Analyst Count
  • ITCI 12
  • GGB 2
  • Target Price
  • ITCI $97.67
  • GGB $5.00
  • AVG Volume (30 Days)
  • ITCI 771.8K
  • GGB 12.0M
  • Earning Date
  • ITCI 10-30-2024
  • GGB 11-05-2024
  • Dividend Yield
  • ITCI N/A
  • GGB 5.09%
  • EPS Growth
  • ITCI N/A
  • GGB N/A
  • EPS
  • ITCI N/A
  • GGB 0.42
  • Revenue
  • ITCI $613,728,000.00
  • GGB $11,922,358,804.00
  • Revenue This Year
  • ITCI $48.25
  • GGB N/A
  • Revenue Next Year
  • ITCI $38.47
  • GGB $2.78
  • P/E Ratio
  • ITCI N/A
  • GGB $7.86
  • Revenue Growth
  • ITCI 46.08
  • GGB N/A
  • 52 Week Low
  • ITCI $58.14
  • GGB $2.92
  • 52 Week High
  • ITCI $93.45
  • GGB $4.11
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 55.65
  • GGB 52.28
  • Support Level
  • ITCI $81.83
  • GGB $3.30
  • Resistance Level
  • ITCI $86.36
  • GGB $3.50
  • Average True Range (ATR)
  • ITCI 2.54
  • GGB 0.10
  • MACD
  • ITCI -0.76
  • GGB 0.00
  • Stochastic Oscillator
  • ITCI 31.15
  • GGB 57.41

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutor, mechanical construction bars, reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives majority of the revenue from the North America Operations segment.

Share on Social Networks: